Published in Vaccine Weekly, December 27th, 2000
This finding is the result of a comparative study of 80 young adults, between the ages of 16 and 35, who were given a combination hepatitis A and B vaccine, or two separate vaccines, one against hepatitis A virus (HAV) and one against hepatitis B virus (HBV).
I.J. Tsai of the National Taiwan University Hospital, along with colleagues in the Department of Pediatrics, described how the experiment was carried out.
"One group received the combined hepatitis A and B vaccine (HAB) in one arm while...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly